Jerry L. Klein

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

F. Anthony Greco, Philip Bonomi, Jeffrey Crawford et al. · Lung Cancer · 2008 · 164 citations

Medicine, Oncology, Pharmacology +17

Long‐term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2012 · 117 citations

Medicine, Clinical Sciences, Pharmacotherapy +11

194 Hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: A radiation therapy oncology group study

Gary B. Stillwagon, Stanley E. Order, Clare E. Guse et al. · International Journal of Radiation Oncology*Biology*Physics · 1989 · 98 citations

Medicine, Oncology, Radiation Oncology +16

Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies

Stanley E. Order, Jerry L. Klein, David S. Ettinger et al. · International Journal of Radiation Oncology*Biology*Physics · 1980 · 89 citations

Medicine, Nuclear Medicine, Oncology +12

Radiation enhancement of radiolabelled antibody deposition in tumors

James S. Msirikale, Jerry L. Klein, John T. Schroeder et al. · International Journal of Radiation Oncology*Biology*Physics · 1987 · 86 citations

Medicine, Oncology, Radiology +13